These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28954820)

  • 1. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
    Couch DG; Tasker C; Theophilidou E; Lund JN; O'Sullivan SE
    Clin Sci (Lond); 2017 Nov; 131(21):2611-2626. PubMed ID: 28954820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
    Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
    Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
    Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
    Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
    Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
    Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
    Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
    Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.
    Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V
    J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
    Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
    Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
    Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
    Cordaro M; Impellizzeri D; Gugliandolo E; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
    Mol Pharmacol; 2016 Nov; 90(5):549-561. PubMed ID: 27625036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.
    Berg BB; Soares JS; Paiva IR; Rezende BM; Rachid MA; Cau SBA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
    J Pharmacol Exp Ther; 2021 May; 377(2):273-283. PubMed ID: 33658314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
    Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
    FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
    Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
    J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
    Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
    Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects.
    D'Aloia A; Molteni L; Gullo F; Bresciani E; Artusa V; Rizzi L; Ceriani M; Meanti R; Lecchi M; Coco S; Costa B; Torsello A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats.
    Marichal-Cancino BA; González-Hernández A; MaassenVanDenBrink A; Ramírez-San Juan E; Villalón CM
    J Vasc Res; 2020; 57(3):152-163. PubMed ID: 32248195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway.
    Sarnelli G; Gigli S; Capoccia E; Iuvone T; Cirillo C; Seguella L; Nobile N; D'Alessandro A; Pesce M; Steardo L; Cuomo R; Esposito G
    Phytother Res; 2016 Jun; 30(6):963-70. PubMed ID: 26929026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
    Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
    Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.